Jazz Pharmaceuticals Plc (JAZZ)
164.89
-0.08
(-0.05%)
USD |
NASDAQ |
Dec 11, 16:00
164.87
-0.02
(-0.01%)
After-Hours: 20:00
Jazz Pharmaceuticals Cash from Investing (Quarterly): -327.80M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Zymeworks, Inc. | 0.31M |
| Alkermes Plc | -6.737M |
| Medtronic Plc | -482.00M |
| Avadel Pharmaceuticals Plc | -8.791M |
| Amarin Corp. Plc | -12.29M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 474.62M |
| Cash from Financing (Quarterly) | -10.83M |
| Free Cash Flow | 1.282B |
| Free Cash Flow Per Share (Quarterly) | 6.971 |
| Free Cash Flow to Equity (Quarterly) | 434.00M |
| Free Cash Flow to Firm (Quarterly) | 2.288B |
| Free Cash Flow Yield | 12.72% |